APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oxycodone Hydrochloride Analgesic

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oxycodone Hydrochloride Analgesic Market Analysis and Forecast 2026-2032

29 December 2025198 pages

Choose your research edition.

Industry ResearchOxycodone Hydrochloride Analgesic Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxycodone Hydrochloride Analgesic Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Oxycodone Hydrochloride Analgesic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxycodone Hydrochloride Analgesic Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxycodone Hydrochloride Analgesic Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oxycodone Hydrochloride Analgesic market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Oxycodone Hydrochloride Analgesic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oxycodone Hydrochloride Analgesic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oxycodone Hydrochloride Analgesic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oxycodone Hydrochloride Analgesic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Oxycodone Hydrochloride Analgesic include Teva Pharmaceutical Industries Ltd, Mylan, Wellso Pharmaceutical, Purdue Pharma, NEPHARM, Napp Pharmaceuticals, Mallinckrodt, Epic Pharma, LLC and Amneal Pharmaceuticals, Inc.（Impax）, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Oxycodone Hydrochloride Analgesic, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oxycodone Hydrochloride Analgesic, also provides the revenue of main regions and countries. Of the upcoming market potential for Oxycodone Hydrochloride Analgesic, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oxycodone Hydrochloride Analgesic revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oxycodone Hydrochloride Analgesic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Oxycodone Hydrochloride Analgesic revenue, projected growth trends, production technology, application and end-user industry.

Oxycodone Hydrochloride Analgesic Segment by Company

Teva Pharmaceutical Industries Ltd

Mylan

Wellso Pharmaceutical

Purdue Pharma

NEPHARM

Napp Pharmaceuticals

Mallinckrodt

Epic Pharma, LLC

Amneal Pharmaceuticals, Inc.（Impax）

Oxycodone Hydrochloride Analgesic Segment by Type

Tablets

Injections

Oxycodone Hydrochloride Analgesic Segment by Application

Hospital

Clinic

Others

Oxycodone Hydrochloride Analgesic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Hydrochloride Analgesic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Hydrochloride Analgesic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Hydrochloride Analgesic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Oxycodone Hydrochloride Analgesic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Oxycodone Hydrochloride Analgesic company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oxycodone Hydrochloride Analgesic revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oxycodone Hydrochloride Analgesic Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablets Major Player Table 3. Injections Major Player Table 4. Global Oxycodone Hydrochloride Analgesic Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Others Major Player Table 8. Oxycodone Hydrochloride Analgesic Industry Trends Table 9. Oxycodone Hydrochloride Analgesic Industry Drivers Table 10. Oxycodone Hydrochloride Analgesic Industry Opportunities and Challenges Table 11. Oxycodone Hydrochloride Analgesic Industry Restraints Table 12. Global Oxycodone Hydrochloride Analgesic Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Oxycodone Hydrochloride Analgesic Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Oxycodone Hydrochloride Analgesic Market Share by Region (2021-2026) Table 15. Global Oxycodone Hydrochloride Analgesic Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Oxycodone Hydrochloride Analgesic Market Share by Region (2027-2032) Table 17. Global Oxycodone Hydrochloride Analgesic Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Players (2021-2026) Table 19. Global Oxycodone Hydrochloride Analgesic Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Oxycodone Hydrochloride Analgesic Key Players Headquarters & Area Served Table 21. Global Oxycodone Hydrochloride Analgesic Players, Product Type & Application Table 22. Global Oxycodone Hydrochloride Analgesic Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Oxycodone Hydrochloride Analgesic by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Oxycodone Hydrochloride Analgesic Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Oxycodone Hydrochloride Analgesic Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Type (2021-2026) Table 29. Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Type (2027-2032) Table 30. Global Oxycodone Hydrochloride Analgesic Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Oxycodone Hydrochloride Analgesic Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Application (2021-2026) Table 34. Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Application (2027-2032) Table 35. Teva Pharmaceutical Industries Ltd Company Information Table 36. Teva Pharmaceutical Industries Ltd Business Overview Table 37. Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Analgesic Product Portfolio Table 39. Teva Pharmaceutical Industries Ltd Recent Development Table 40. Mylan Company Information Table 41. Mylan Business Overview Table 42. Mylan Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Mylan Oxycodone Hydrochloride Analgesic Product Portfolio Table 44. Mylan Recent Development Table 45. Wellso Pharmaceutical Company Information Table 46. Wellso Pharmaceutical Business Overview Table 47. Wellso Pharmaceutical Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Wellso Pharmaceutical Oxycodone Hydrochloride Analgesic Product Portfolio Table 49. Wellso Pharmaceutical Recent Development Table 50. Purdue Pharma Company Information Table 51. Purdue Pharma Business Overview Table 52. Purdue Pharma Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Purdue Pharma Oxycodone Hydrochloride Analgesic Product Portfolio Table 54. Purdue Pharma Recent Development Table 55. NEPHARM Company Information Table 56. NEPHARM Business Overview Table 57. NEPHARM Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. NEPHARM Oxycodone Hydrochloride Analgesic Product Portfolio Table 59. NEPHARM Recent Development Table 60. Napp Pharmaceuticals Company Information Table 61. Napp Pharmaceuticals Business Overview Table 62. Napp Pharmaceuticals Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Napp Pharmaceuticals Oxycodone Hydrochloride Analgesic Product Portfolio Table 64. Napp Pharmaceuticals Recent Development Table 65. Mallinckrodt Company Information Table 66. Mallinckrodt Business Overview Table 67. Mallinckrodt Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Mallinckrodt Oxycodone Hydrochloride Analgesic Product Portfolio Table 69. Mallinckrodt Recent Development Table 70. Epic Pharma, LLC Company Information Table 71. Epic Pharma, LLC Business Overview Table 72. Epic Pharma, LLC Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Epic Pharma, LLC Oxycodone Hydrochloride Analgesic Product Portfolio Table 74. Epic Pharma, LLC Recent Development Table 75. Amneal Pharmaceuticals, Inc.（Impax） Company Information Table 76. Amneal Pharmaceuticals, Inc.（Impax） Business Overview Table 77. Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Analgesic Product Portfolio Table 79. Amneal Pharmaceuticals, Inc.（Impax） Recent Development Table 80. North America Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2026) & (US$ Million) Table 81. North America Oxycodone Hydrochloride Analgesic Revenue by Type (2027-2032) & (US$ Million) Table 82. North America Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Oxycodone Hydrochloride Analgesic Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Oxycodone Hydrochloride Analgesic Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Oxycodone Hydrochloride Analgesic Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Oxycodone Hydrochloride Analgesic Revenue by Country (US$ Million) & (2027-2032) Table 87. Europe Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2026) & (US$ Million) Table 88. Europe Oxycodone Hydrochloride Analgesic Revenue by Type (2027-2032) & (US$ Million) Table 89. Europe Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2026) & (US$ Million) Table 90. Europe Oxycodone Hydrochloride Analgesic Revenue by Application (2027-2032) & (US$ Million) Table 91. Europe Oxycodone Hydrochloride Analgesic Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Oxycodone Hydrochloride Analgesic Revenue by Country (2021-2026) & (US$ Million) Table 93. Europe Oxycodone Hydrochloride Analgesic Revenue by Country (US$ Million) & (2027-2032) Table 94. China Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2026) & (US$ Million) Table 95. China Oxycodone Hydrochloride Analgesic Revenue by Type (2027-2032) & (US$ Million) Table 96. China Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2026) & (US$ Million) Table 97. China Oxycodone Hydrochloride Analgesic Revenue by Application (2027-2032) & (US$ Million) Table 98. Asia Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2026) & (US$ Million) Table 99. Asia Oxycodone Hydrochloride Analgesic Revenue by Type (2027-2032) & (US$ Million) Table 100. Asia Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2026) & (US$ Million) Table 101. Asia Oxycodone Hydrochloride Analgesic Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia Oxycodone Hydrochloride Analgesic Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Oxycodone Hydrochloride Analgesic Revenue by Region (US$ Million) & (2021-2026) Table 104. Asia Oxycodone Hydrochloride Analgesic Revenue by Region (US$ Million) & (2027-2032) Table 105. SAMEA Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2026) & (US$ Million) Table 106. SAMEA Oxycodone Hydrochloride Analgesic Revenue by Type (2027-2032) & (US$ Million) Table 107. SAMEA Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2026) & (US$ Million) Table 108. SAMEA Oxycodone Hydrochloride Analgesic Revenue by Application (2027-2032) & (US$ Million) Table 109. SAMEA Oxycodone Hydrochloride Analgesic Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. SAMEA Oxycodone Hydrochloride Analgesic Revenue by Country (2021-2026) & (US$ Million) Table 111. SAMEA Oxycodone Hydrochloride Analgesic Revenue by Country (US$ Million) & (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Oxycodone Hydrochloride Analgesic Image Figure 2. Global Oxycodone Hydrochloride Analgesic Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oxycodone Hydrochloride Analgesic Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablets Image Figure 5. Injections Image Figure 6. Global Oxycodone Hydrochloride Analgesic Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Oxycodone Hydrochloride Analgesic Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Oxycodone Hydrochloride Analgesic Market Size (US$ Million) & (2021-2032) Figure 12. Global Oxycodone Hydrochloride Analgesic Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Oxycodone Hydrochloride Analgesic Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Oxycodone Hydrochloride Analgesic Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Oxycodone Hydrochloride Analgesic Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Oxycodone Hydrochloride Analgesic Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Type (2021-2032) Figure 19. Global Oxycodone Hydrochloride Analgesic Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Application (2021-2032) Figure 22. North America Oxycodone Hydrochloride Analgesic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Oxycodone Hydrochloride Analgesic Revenue Share by Type (2021-2032) Figure 24. North America Oxycodone Hydrochloride Analgesic Revenue Share by Application (2021-2032) Figure 25. North America Oxycodone Hydrochloride Analgesic Revenue Share by Country (2021-2032) Figure 26. United States Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Oxycodone Hydrochloride Analgesic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Oxycodone Hydrochloride Analgesic Revenue Share by Type (2021-2032) Figure 31. Europe Oxycodone Hydrochloride Analgesic Revenue Share by Application (2021-2032) Figure 32. Europe Oxycodone Hydrochloride Analgesic Revenue Share by Country (2021-2032) Figure 33. Germany Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Oxycodone Hydrochloride Analgesic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Oxycodone Hydrochloride Analgesic Revenue Share by Type (2021-2032) Figure 43. China Oxycodone Hydrochloride Analgesic Revenue Share by Application (2021-2032) Figure 44. Asia Oxycodone Hydrochloride Analgesic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Oxycodone Hydrochloride Analgesic Revenue Share by Type (2021-2032) Figure 46. Asia Oxycodone Hydrochloride Analgesic Revenue Share by Application (2021-2032) Figure 47. Asia Oxycodone Hydrochloride Analgesic Revenue Share by Region (2021-2032) Figure 48. Japan Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Oxycodone Hydrochloride Analgesic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Oxycodone Hydrochloride Analgesic Revenue Share by Type (2021-2032) Figure 56. SAMEA Oxycodone Hydrochloride Analgesic Revenue Share by Application (2021-2032) Figure 57. SAMEA Oxycodone Hydrochloride Analgesic Revenue Share by Country (2021-2032) Figure 58. Brazil Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Oxycodone Hydrochloride Analgesic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Injections
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva Pharmaceutical Industries Ltd
  • Mylan
  • Wellso Pharmaceutical
  • Purdue Pharma
  • NEPHARM
  • Napp Pharmaceuticals
  • Mallinckrodt
  • Epic Pharma, LLC
  • Amneal Pharmaceuticals, Inc.（Impax）

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oxycodone Hydrochloride Analgesic Market by Type
  3. 1.2.1 Global Oxycodone Hydrochloride Analgesic Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablets
  5. 1.2.3 Injections
  6. 1.3 Oxycodone Hydrochloride Analgesic Market by Application
  7. 1.3.1 Global Oxycodone Hydrochloride Analgesic Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Oxycodone Hydrochloride Analgesic Market Dynamics
  1. 2.1 Oxycodone Hydrochloride Analgesic Industry Trends
  2. 2.2 Oxycodone Hydrochloride Analgesic Industry Drivers
  3. 2.3 Oxycodone Hydrochloride Analgesic Industry Opportunities and Challenges
  4. 2.4 Oxycodone Hydrochloride Analgesic Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Oxycodone Hydrochloride Analgesic Market Perspective (2021-2032)
  2. 3.2 Global Oxycodone Hydrochloride Analgesic Growth Trends by Region
  3. 3.2.1 Global Oxycodone Hydrochloride Analgesic Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oxycodone Hydrochloride Analgesic Market Size by Region (2021-2026)
  5. 3.2.3 Global Oxycodone Hydrochloride Analgesic Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Oxycodone Hydrochloride Analgesic Revenue by Players
  2. 4.1.1 Global Oxycodone Hydrochloride Analgesic Revenue by Players (2021-2026)
  3. 4.1.2 Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Oxycodone Hydrochloride Analgesic Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oxycodone Hydrochloride Analgesic Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Oxycodone Hydrochloride Analgesic Key Players Headquarters & Area Served
  7. 4.4 Global Oxycodone Hydrochloride Analgesic Players, Product Type & Application
  8. 4.5 Global Oxycodone Hydrochloride Analgesic Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Oxycodone Hydrochloride Analgesic Market CR5 and HHI
  11. 4.6.3 2025 Oxycodone Hydrochloride Analgesic Tier 1, Tier 2, and Tier 3
5 Oxycodone Hydrochloride Analgesic Market Size by Type
  1. 5.1 Global Oxycodone Hydrochloride Analgesic Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2032)
  3. 5.3 Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Type (2021-2032)
6 Oxycodone Hydrochloride Analgesic Market Size by Application
  1. 6.1 Global Oxycodone Hydrochloride Analgesic Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2032)
  3. 6.3 Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Teva Pharmaceutical Industries Ltd
  2. 7.1.1 Teva Pharmaceutical Industries Ltd Company Information
  3. 7.1.2 Teva Pharmaceutical Industries Ltd Business Overview
  4. 7.1.3 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Analgesic Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
  7. 7.2 Mylan
  8. 7.2.1 Mylan Company Information
  9. 7.2.2 Mylan Business Overview
  10. 7.2.3 Mylan Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Mylan Oxycodone Hydrochloride Analgesic Product Portfolio
  12. 7.2.5 Mylan Recent Developments
  13. 7.3 Wellso Pharmaceutical
  14. 7.3.1 Wellso Pharmaceutical Company Information
  15. 7.3.2 Wellso Pharmaceutical Business Overview
  16. 7.3.3 Wellso Pharmaceutical Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Wellso Pharmaceutical Oxycodone Hydrochloride Analgesic Product Portfolio
  18. 7.3.5 Wellso Pharmaceutical Recent Developments
  19. 7.4 Purdue Pharma
  20. 7.4.1 Purdue Pharma Company Information
  21. 7.4.2 Purdue Pharma Business Overview
  22. 7.4.3 Purdue Pharma Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Purdue Pharma Oxycodone Hydrochloride Analgesic Product Portfolio
  24. 7.4.5 Purdue Pharma Recent Developments
  25. 7.5 NEPHARM
  26. 7.5.1 NEPHARM Company Information
  27. 7.5.2 NEPHARM Business Overview
  28. 7.5.3 NEPHARM Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  29. 7.5.4 NEPHARM Oxycodone Hydrochloride Analgesic Product Portfolio
  30. 7.5.5 NEPHARM Recent Developments
  31. 7.6 Napp Pharmaceuticals
  32. 7.6.1 Napp Pharmaceuticals Company Information
  33. 7.6.2 Napp Pharmaceuticals Business Overview
  34. 7.6.3 Napp Pharmaceuticals Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Napp Pharmaceuticals Oxycodone Hydrochloride Analgesic Product Portfolio
  36. 7.6.5 Napp Pharmaceuticals Recent Developments
  37. 7.7 Mallinckrodt
  38. 7.7.1 Mallinckrodt Company Information
  39. 7.7.2 Mallinckrodt Business Overview
  40. 7.7.3 Mallinckrodt Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Mallinckrodt Oxycodone Hydrochloride Analgesic Product Portfolio
  42. 7.7.5 Mallinckrodt Recent Developments
  43. 7.8 Epic Pharma, LLC
  44. 7.8.1 Epic Pharma, LLC Company Information
  45. 7.8.2 Epic Pharma, LLC Business Overview
  46. 7.8.3 Epic Pharma, LLC Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Epic Pharma, LLC Oxycodone Hydrochloride Analgesic Product Portfolio
  48. 7.8.5 Epic Pharma, LLC Recent Developments
  49. 7.9 Amneal Pharmaceuticals, Inc.（Impax）
  50. 7.9.1 Amneal Pharmaceuticals, Inc.（Impax） Company Information
  51. 7.9.2 Amneal Pharmaceuticals, Inc.（Impax） Business Overview
  52. 7.9.3 Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Analgesic Product Portfolio
  54. 7.9.5 Amneal Pharmaceuticals, Inc.（Impax） Recent Developments
8 North America
  1. 8.1 North America Oxycodone Hydrochloride Analgesic Revenue (2021-2032)
  2. 8.2 North America Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2032)
  3. 8.2.1 North America Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2026)
  4. 8.2.2 North America Oxycodone Hydrochloride Analgesic Revenue by Type (2027-2032)
  5. 8.3 North America Oxycodone Hydrochloride Analgesic Revenue Share by Type (2021-2032)
  6. 8.4 North America Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2032)
  7. 8.4.1 North America Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2026)
  8. 8.4.2 North America Oxycodone Hydrochloride Analgesic Revenue by Application (2027-2032)
  9. 8.5 North America Oxycodone Hydrochloride Analgesic Revenue Share by Application (2021-2032)
  10. 8.6 North America Oxycodone Hydrochloride Analgesic Revenue by Country
  11. 8.6.1 North America Oxycodone Hydrochloride Analgesic Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Oxycodone Hydrochloride Analgesic Revenue by Country (2021-2026)
  13. 8.6.3 North America Oxycodone Hydrochloride Analgesic Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Oxycodone Hydrochloride Analgesic Revenue (2021-2032)
  2. 9.2 Europe Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2032)
  3. 9.2.1 Europe Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2026)
  4. 9.2.2 Europe Oxycodone Hydrochloride Analgesic Revenue by Type (2027-2032)
  5. 9.3 Europe Oxycodone Hydrochloride Analgesic Revenue Share by Type (2021-2032)
  6. 9.4 Europe Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2032)
  7. 9.4.1 Europe Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2026)
  8. 9.4.2 Europe Oxycodone Hydrochloride Analgesic Revenue by Application (2027-2032)
  9. 9.5 Europe Oxycodone Hydrochloride Analgesic Revenue Share by Application (2021-2032)
  10. 9.6 Europe Oxycodone Hydrochloride Analgesic Revenue by Country
  11. 9.6.1 Europe Oxycodone Hydrochloride Analgesic Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Oxycodone Hydrochloride Analgesic Revenue by Country (2021-2026)
  13. 9.6.3 Europe Oxycodone Hydrochloride Analgesic Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Oxycodone Hydrochloride Analgesic Revenue (2021-2032)
  2. 10.2 China Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2032)
  3. 10.2.1 China Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2026)
  4. 10.2.2 China Oxycodone Hydrochloride Analgesic Revenue by Type (2027-2032)
  5. 10.3 China Oxycodone Hydrochloride Analgesic Revenue Share by Type (2021-2032)
  6. 10.4 China Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2032)
  7. 10.4.1 China Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2026)
  8. 10.4.2 China Oxycodone Hydrochloride Analgesic Revenue by Application (2027-2032)
  9. 10.5 China Oxycodone Hydrochloride Analgesic Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oxycodone Hydrochloride Analgesic Revenue (2021-2032)
  2. 11.2 Asia Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2032)
  3. 11.2.1 Asia Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2026)
  4. 11.2.2 Asia Oxycodone Hydrochloride Analgesic Revenue by Type (2027-2032)
  5. 11.3 Asia Oxycodone Hydrochloride Analgesic Revenue Share by Type (2021-2032)
  6. 11.4 Asia Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2032)
  7. 11.4.1 Asia Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2026)
  8. 11.4.2 Asia Oxycodone Hydrochloride Analgesic Revenue by Application (2027-2032)
  9. 11.5 Asia Oxycodone Hydrochloride Analgesic Revenue Share by Application (2021-2032)
  10. 11.6 Asia Oxycodone Hydrochloride Analgesic Revenue by Country
  11. 11.6.1 Asia Oxycodone Hydrochloride Analgesic Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Oxycodone Hydrochloride Analgesic Revenue by Country (2021-2026)
  13. 11.6.3 Asia Oxycodone Hydrochloride Analgesic Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oxycodone Hydrochloride Analgesic Revenue (2021-2032)
  2. 12.2 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Type (2027-2032)
  5. 12.3 SAMEA Oxycodone Hydrochloride Analgesic Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Application (2027-2032)
  9. 12.5 SAMEA Oxycodone Hydrochloride Analgesic Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Country
  11. 12.6.1 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst